APOE ɛ4 alone is not sufficiently sensitive or specific for AD24 and further studies are needed on applications of PRS (which are typically composed of many genetic variants with small effects on disease risk25), beyond the classification of AD cases and controls. The gene discussed is APOE; the disease is Alzheimer disease.